PNC Financial Services Group
COGT icon

PNC Financial Services Group’s Cogent Biosciences COGT Stock Holding History

PNC Financial Services Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.3K Buy
1,893
+460
+32% +$16.1K ﹤0.01% 3114
2026
Q1 		$55.2K Buy
1,433
+152
+12% +$5.61K ﹤0.01% 3168
2025
Q4 		$45.5K Buy
1,281
+1,032
+414% +$29K ﹤0.01% 3265
2025
Q3 		$3.58K Buy
249
+8
+3% +$95 ﹤0.01% 4328
2025
Q2 		$1.73K Buy
241
+177
+277% +$981 ﹤0.01% 4452
2025
Q1 		$383 Hold
64
– – ﹤0.01% 4687
2024
Q4 		$499 Hold
64
– – ﹤0.01% 4530
2024
Q3 		$691 Hold
64
– – ﹤0.01% 4517
2024
Q2 		$540 Buy
64
+44
+220% +$334 ﹤0.01% 4517
2024
Q1 		$134 Sell
20
-134
-87% -$828 ﹤0.01% 4638
2023
Q4 		$906 Buy
+154
New +$1.18K ﹤0.01% 4333

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

PNC Financial Services Group's COGT Position: Q2 2026 in Review

PNC Financial Services Group increased its Cogent Biosciences (COGT) stake by 32% in Q2 2026, buying an estimated $16.1K and bringing the position to 1,893 shares worth $73.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

PNC Financial Services Group first reported a position in COGT in Q4 2023 and has held it in 11 quarters since. 102 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • PNC Financial Services Group held 1,893 shares of Cogent Biosciences worth $73.3K as of Q2 2026.
  • PNC Financial Services Group bought 460 Cogent Biosciences shares in Q2 2026, an estimated $16.1K.
  • Cogent Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3114 holding.
  • PNC Financial Services Group first reported a position in Cogent Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 102 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.